CHIGENOVO Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
70
- Latest Deal Type
-
Series B2
- Latest Deal Amount
-
$16.6M
- Investors
-
12
CHIGENOVO General Information
Description
Developer of clinical genetic diagnosis, fertility prevention and gene therapy drug for hereditary eye diseases. The company specializes in developing ophthalmic gene therapy drugs backed by accurate gene diagnosis, providing reliable ophthalmic gene pharmaceuticals for the public.
Contact Information
Website
www.chigenovo.comCorporate Office
- Area D, Building 1, Number 27, Life Park Road
- Zhongguancun Life Science Park, Changping District
- Beijing, 102206
- China
Corporate Office
- Area D, Building 1, Number 27, Life Park Road
- Zhongguancun Life Science Park, Changping District
- Beijing, 102206
- China
CHIGENOVO Timeline
CHIGENOVO Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B2) | 20-May-2026 | $16.6M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series B1) | 16-Sep-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 27-Sep-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 24-Mar-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 20-Jun-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series 2) | 28-Dec-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 22-May-2019 | $2.19M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series 1) | 01-Oct-2018 | $2.19M | $2.19M | Completed | Generating Revenue |
CHIGENOVO Comparisons
Industry
Financing
Details
CHIGENOVO Competitors (2)
One of CHIGENOVO’s 2 competitors is Spark Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Spark Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| MeiraGTx | Formerly VC-backed | New York, NY |
CHIGENOVO Signals
CHIGENOVO Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| C-MER Medical Holdings | Corporation | Minority | ||
| Kunlun Capital | Family Office | Minority | ||
| Huayi Capital | Venture Capital | Minority | ||
| Junci Investment | Growth/Expansion | Minority | ||
| Lapam Capital | Venture Capital | Minority |
CHIGENOVO Investments (1)
CHIGENOVO’s most recent deal was a Early Stage VC with Ubrigene for . The deal was made on 18-Oct-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ubrigene | 18-Oct-2019 | Early Stage VC | Other Pharmaceuticals and Biotechnology |
CHIGENOVO FAQs
-
When was CHIGENOVO founded?
CHIGENOVO was founded in 2016.
-
Where is CHIGENOVO headquartered?
CHIGENOVO is headquartered in Beijing, China.
-
What is the size of CHIGENOVO?
CHIGENOVO has 70 total employees.
-
What industry is CHIGENOVO in?
CHIGENOVO’s primary industry is Drug Discovery.
-
Is CHIGENOVO a private or public company?
CHIGENOVO is a Private company.
-
What is the current valuation of CHIGENOVO?
The current valuation of CHIGENOVO is .
-
What is CHIGENOVO’s current revenue?
The current revenue for CHIGENOVO is .
-
How much funding has CHIGENOVO raised over time?
CHIGENOVO has raised $57.6M.
-
Who are CHIGENOVO’s investors?
C-MER Medical Holdings, Kunlun Capital, Huayi Capital, Junci Investment, and Lapam Capital are 5 of 12 investors who have invested in CHIGENOVO.
-
Who are CHIGENOVO’s competitors?
Spark Therapeutics and MeiraGTx are competitors of CHIGENOVO.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process